Clinical Trials in Georgia

Showing 4721-4740 of 14,426 trials

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

NCT05709444

This is a prospective, open-label trial to assess the efficacy of melanocortin receptor agonist bremelanotide (BMT) when administered with RAAS inhibition therapy after six months in subjects with Type II diabetic nephropathy. After six months of therapy, all subjects will remain in trial for further assessment and undergo a diagnostic renal biopsy to assess the effect of melanocortin therapy on diabetic histopathology at 12 months.

Kidney Disease

Palatin Technologies, Inc16 participantsStarted Dec 2022

Chula Vista, California, United States • La Mesa, California, United States • Decatur, Georgia, United States +6 more locations

COMPLETED65 miles

Assessment of Macrophage Activation syndromE in STill's Disease

NCT06405152

Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics

Macrophage Activation SyndromeStill's Disease, Adult-OnsetStills Disease, Juvenile-Onset

Swedish Orphan Biovitrum75 participantsStarted Sep 2023

Los Angeles, California, United States • Atlanta, Georgia, United States • Cincinnati, Ohio, United States +8 more locations

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

Assessment of Macrophage Activation syndromE in STill's Disease

Find Trials by Condition in Georgia

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System

A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty

A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Vogelxo(R) ABPM Study in Hypogandal Men

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

PK and Dose Escalation and Expansion Study of DST-2970

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Milademetan in Advanced/Metastatic Solid Tumors

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Stockholm3 Validation Study in a Multi-Ethnic Cohort